Praxis Precision Medicines
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$123,277,000 and profit margin reached -5038%. Total operating expenses were $128,820,000.

Profit Margin

Praxis Precision Medicines, Inc. (NASDAQ:PRAX): Profit margin
2018 0 -26.53M
2019 0 -35.51M
2020 0 -61.82M
2021 0 -166.87M
2022 0 -213.07M
2023 2.44M -123.27M -5037.88%

PRAX Income Statement (2018 – 2023)

2023 2022 2021 2020 2019 2018
Revenue
Revenue
2.44M00000
Cost of revenue
01.17M1.59M746K679K0
Gross profit
2.44M-1.17M-1.59M-746K-679K0
Operating exp.
Research and development
86.76M155.04M120.25M44.97M29.55M18.82M
Selling and marketing
000000
Total operating expenses
128.82M214.98M167.33M61.96M35.78M22.71M
Operating income
-126.37M-214.98M-167.33M-61.96M-35.78M-22.71M
Other income (expenses), net
3.09M957K271K140K193K-3.64M
Income before tax
-123.27M-214.02M-167.06M-61.82M-35.59M-26.40M
Income tax expense
0-957K-182K-8K-84K133K
Net income
-123.27M-213.07M-166.87M-61.82M-35.51M-26.53M
Earnings per share
Basic EPS
-18.69-69.33-58.96-103.61-348.24-306.73
Diluted EPS
-18.69-69.33-58.96-103.61-348.24-306.73
Data sourceData sourceData sourceData source